Environmental triggers of the immune system play an important role in the development of Sjögren's syndrome.
The disease-fighting capacity of the body depends on the proper functioning of its immune system. Hence, a new discovery revealing new insight into its functioning by University of Queensland (UQ) researchers could reveal new ways to treat diseases like cancer and autoimmune disorders.
Edinburgh, Scotland based Synpromics has teamed up with UCL Great Ormond Street Institute of Child Health to develop novel gene therapies for diseases affecting the haematopoietic system.
Boston biotech resTORbio has pocketed another $40 million from a second-round financing that it hopes gives it enough cash to move its lead candidate for respiratory tract infections in elderly patients into phase 3.
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.